Back to top
more

Canopy Growth (CGC)

(Delayed Data from NSDQ)

$1.05 USD

1.05
6,969,525

+0.02 (1.94%)

Updated Aug 1, 2025 04:00 PM ET

After-Market: $1.06 +0.01 (0.95%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value B Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 30% (173 out of 246)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Sanghamitra Saha headshot

Top ETF Stories of August

by Sanghamitra Saha

Inside the eye-catching ETF events of August.

    Sweta Killa headshot

    5 Best Stocks of the Top ETF of August

    by Sweta Killa

    Cannabis-related ETFMG Alternative Harvest ETF (MJ) is the best-performing ETF of August, gaining 22.5% and attracting $22 million in AUM.

      Zacks Equity Research

      Canopy Growth (CGC) Jumps: Stock Rises 7.4%

      by Zacks Equity Research

      Canopy Growth (CGC) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.

        Benjamin Rains headshot

        What Investors Need to Know About Investing In Marijuana Stocks

        by Benjamin Rains

        Marijuana has come a long way since California legalized cannabis for medicinal use back in 1996. Today, the industry and marijuana look to be on the cusp of unprecedented acceptance, with major international giants investing billions into publicly traded cannabis companies. So let's take a look at what investors need to know about the marijuana industry and how to invest in the future of pot.

          Sanghamitra Saha headshot

          Pot Stocks Are on a High: Play These Cannabis ETFs

          by Sanghamitra Saha

          Beverage companies are eyeing the cannabis market aggressively for making pot-infused drinks. Play the binge with these ETFs.

            Zacks Equity Research

            Zacks Industry Outlook Highlights: Anheuser-Busch, Constellation, Canopy Growth and Brown-Forman.

            by Zacks Equity Research

            Zacks Industry Outlook Highlights: Anheuser-Busch, Constellation, Canopy Growth and Brown-Forman.

              Zacks Equity Research

              Alcohol Outlook: Soft Beer Demand & High Costs to Hurt

              by Zacks Equity Research

              The Beverages - Alcohol industry is in the doldrums due to softness in the beer segment, the consumers' shift to healthy options and higher aluminum costs, which is hurting investors' confidence.

                Sanghamitra Saha headshot

                Follow Constellation Brands, Bet Big on Cannabis ETFs

                by Sanghamitra Saha

                Cannabis ETFs take a leap as Constellation Brands boosted its share in cannabis company Canopy Growth.

                  Ryan McQueeney headshot

                  Pot Stocks, Tesla, Pepsi Buys SodaStream, & Retail Earnings | Free Lunch

                  by Ryan McQueeney

                  Ryan McQueeney touches on today's mixed news related to Tesla and Pepsi's acquisition of SodaStream. He also investigates the recent momentum of popular cannabis stocks like Canopy Growth, Cronos Group, and Tilray. Later, the host previews upcoming earnings reports from the retail sector.

                    Zacks Equity Research

                    Canopy Growth (CGC) in Focus: Stock Moves 9.2% Higher

                    by Zacks Equity Research

                    Canopy Growth (CGC) shares rose more than 9% in the last trading session, amid huge volumes.

                      Zacks Equity Research

                      Constellation Brands Invests in Cannabis, Expands Canopy Stake

                      by Zacks Equity Research

                      Constellation Brands (STZ) expands its stake in Canada's Canopy Growth Corporation to 38% through an additional $5-billion investment.

                        Ryan McQueeney headshot

                        Buffett Buys More Apple, GE Falls Further, & Turkey Weighs on Stocks | Free Lunch

                        by Ryan McQueeney

                        Ryan McQueeney discusses the morning's top market headlines, including the effect of the Turkish crisis on U.S. stocks, GE's historic low point, Corona's new marijuana investment, and earnings from retail giant Macy's. Later, he checks in with Warren Buffett's latest holdings and discusses the investing icon's take in Apple.

                          Benjamin Rains headshot

                          CRON, CGC Sink Ahead of Earnings: What To Watch From These Pot Stocks

                          by Benjamin Rains

                          Recreational marijuana is now legal in Canada as well as a number of states in the U.S. Companies have raced to get in on the multibillion-dollar a year industry, so let's see how two of the bigger pure-play pot stocks, Cronos Group (CRON) and Canopy Growth (CGC), are projected to perform Tuesday.

                            Zacks Equity Research

                            Can Tenet Healthcare (THC) Keep Earnings Beat Alive in Q2?

                            by Zacks Equity Research

                            Tenet Healthcare (THC) is likely to repeat its success story in Q2 on the back of a strong performance at the Conifer segment as well as its key initiatives.

                              Nimah Quadri headshot

                              Molson Coors Plans to Create Cannabis-Infused Beverages to Prevent Decline of Beer Sales

                              by Nimah Quadri

                              Just recently, Canada became the second nation to legalize the use of recreational marijuana after the Senate passed a bill with a vote of 52-29.

                                Ryan McQueeney headshot

                                2 Pot Stocks to Watch As Canada Legalizes Marijuana

                                by Ryan McQueeney

                                Major news out of Canada this week brought renewed attention to the legal marijuana industry, with the North American nation becoming just the second country in the world to legalize a statewide recreational cannabis market. Here are two stocks trading on U.S. exchanges to watch now.

                                  Ryan McQueeney headshot

                                  Cronos (CRON) and 2 Other Weed Stocks Moving Higher As Canada Legalizes

                                  by Ryan McQueeney

                                  Shares of several notable Canadian marijuana companies--including Cronos Group (CRON), Canopy Growth (CGC), and Aurora Cannabis (ACBFF)--moved higher in early morning trading Wednesday on the back of news that recreational marijuana will soon be legal in the country.